NeuroPace Newsroom

Wells Fargo Maintains NeuroPace(NPCE.US) With Buy Rating, Maintains Target Price $13

Moomoo NewsNov 22 07:31 ET

NeuroPace Is Maintained at Overweight by Wells Fargo

Dow JonesNov 13 12:29 ET

NeuroPace Analyst Ratings

BenzingaNov 13 12:20 ET

Morgan Stanley Maintains NeuroPace(NPCE.US) With Hold Rating, Maintains Target Price $8

Moomoo NewsNov 13 08:36 ET

Wells Fargo Maintains NeuroPace(NPCE.US) With Buy Rating, Cuts Target Price to $13

Moomoo NewsNov 13 06:31 ET

NeuroPace's Strong Financial Performance and Strategic Advancements Justify Buy Rating

TipRanksNov 13 05:43 ET

Lake Street Maintains NeuroPace(NPCE.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsNov 12 09:35 ET

Lake Street Maintains NeuroPace(NPCE.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsNov 11 09:31 ET

Lake Street Maintains NeuroPace(NPCE.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsSep 5 09:31 ET

NeuroPace (NPCE) Gets a Buy From Lake Street

TipRanksSep 5 08:49 ET

A Quick Look at Today's Ratings for NeuroPace(NPCE.US), With a Forecast Between $8 to $20

Moomoo NewsAug 15 09:03 ET

NeuroPace Analyst Ratings

BenzingaAug 14 09:30 ET

Wells Fargo Maintains NeuroPace(NPCE.US) With Buy Rating, Cuts Target Price to $15

Moomoo NewsAug 14 07:34 ET

Lake Street Maintains NeuroPace(NPCE.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsAug 13 09:33 ET

NeuroPace Analyst Ratings

BenzingaJul 15 12:58 ET

Morgan Stanley Lowers Price Target on NeuroPace to $8 From $9.50, Keeps Equalweight Rating

MT NewswiresJul 15 07:12 ET

Strong Sales Growth and Strategic Initiatives Justify Buy Rating for NeuroPace

TipRanksMay 29 05:50 ET

Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating

MT NewswiresMay 13 06:54 ET

NeuroPace's Strong Q1 Performance and Promising Growth Prospects Affirm Buy Rating

TipRanksMay 10 01:30 ET

NeuroPace Analyst Ratings

BenzingaMay 9 11:11 ET